Press Release

Discussion to Cover Current Scientific Advancements and the Importance of Accurate and Early Detection October 15, 2020 – Ontario, Canada – Signpost Cancer Analytics Inc. Inc. (“SignPost” or “company”), a company developing an advanced molecular diagnostic test to identify invasive breast cancer is pleased to be participating on the panel for the New York Chapter…

September 14, 2020 – Ontario, Canada – Signpost Cancer Analytics Inc. Inc. (“SignPost” or “company”), a company developing an advanced molecular diagnostic test to identify invasive breast cancer is pleased to be presenting at the Midwest Venture Capital Consortium.  The event will be held virtually on Monday, September 14, 2020, from 3-4pmCT. SignPost will be…

DNA Methylation Multivariate Biomarkers Offers 98% Specificity and Sensitivity July 28, 2020 – Ontario, Canada – Signpost Cancer Analytics Inc. Inc. (“SignPost” or “company”), a company developing an advanced molecular diagnostic test to identify invasive breast cancer, is pleased to announce the filing of a provisional patent for the company’s lead diagnostic test – BreastDefense.…

July 8, 2020 – Ontario, Canada – Signpost Cancer Analytics Inc. Inc. (“SignPost” or “company”), a company developing an advanced diagnostic test to identify invasive breast cancer has retained Zimmons International Communications, Inc. (“Zimmons International”), based in New York City, as the company”‘s financial communications counselor and investor relations firm. Zimmons International will assist SignPost…